Venture Capital Investments	6 Months Ended
Jul. 01, 2017
Equity Method Investments and Joint Ventures [Abstract]
VENTURE CAPITAL INVESTMENTS	VENTURE CAPITAL INVESTMENTS The Company invests in several venture capital funds that invest in start-up companies, primarily in the life sciences industry. The Company’s ownership interest in these funds ranges from 0.7% to 12.0%. The Company accounts for the investments in limited partnerships (LPs), which are variable interest entities, under the equity or cost method of accounting. The Company is not the primary beneficiary because it has no power to direct the activities that most significantly affect the LPs’ economic performance. The Company accounts for the investments in limited liability companies, which are not variable interest entities, under the equity method of accounting. The Company’s total commitments to the entities as of July 1, 2017, were $87.7 million, of which the Company funded $45.5 million through that date. During the three and six months ended July 1, 2017, the Company received dividends of zero and $4.4 million, respectively, from the entities. During the three and six months ended June 25, 2016, the Company received no dividends from the entities. The Company recognized gains of $2.5 million and $5.0 million related to these investments for the three months ended July 1, 2017 and June 25, 2016, respectively. The Company recognized gains of $6.7 million and $8.1 million related to these investments for the six months ended July 1, 2017 and June 25, 2016, respectively.

VENTURE CAPITAL INVESTMENTS

The Company invests in several venture capital funds that invest in start-up companies, primarily in the life sciences industry. The Company’s ownership interest in these funds ranges from 0.7% to 12.0%. The Company accounts for the investments in limited partnerships (LPs), which are variable interest entities, under the equity or cost method of accounting. The Company is not the primary beneficiary because it has no power to direct the activities that most significantly affect the LPs’ economic performance. The Company accounts for the investments in limited liability companies, which are not variable interest entities, under the equity method of accounting.

The Company’s total commitments to the entities as of July 1, 2017, were $87.7 million, of which the Company funded $45.5 million through that date. During the three and six months ended July 1, 2017, the Company received dividends of zero and $4.4 million, respectively, from the entities. During the three and six months ended June 25, 2016, the Company received no dividends from the entities. The Company recognized gains of $2.5 million and $5.0 million related to these investments for the three months ended July 1, 2017 and June 25, 2016, respectively. The Company recognized gains of $6.7 million and $8.1 million related to these investments for the six months ended July 1, 2017 and June 25, 2016, respectively.